CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
细胞因子诱导的杀伤（CIK）细胞，成功与挑战：关于首次专门针对这种独特过继性细胞免疫疗法临床转化的国际会议的报告
英文原题：Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.
查看英文原题
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
中文摘要
2023年8月30日，来自德国及国外的专家齐聚一堂，讨论细胞因子诱导的杀伤细胞（CIK）疗法的成功与挑战，该疗法最近迎来了其提供癌症治疗的30周年。这次首次虚拟会议由CIO Bonn主办，该机构是由德国癌症援助组织（DKH）资助的认证综合癌症中心（CCC）。除了参与CIK细胞临床试验或优化临床前模型以改进这种过继性细胞免疫疗法的主题演讲者外，来自世界各地的100多名与会者也参加了此次活动。会议还宣布了建立国际CIK细胞学会（ISCC）以及更强大的CIK细胞网络以指导临床前研究和未来临床试验的倡议。
展开英文摘要原文
On August 30, 2023, experts from Germany and abroad met to discuss the successes and challenges of cytokine-induced killer cell (CIK) therapy, that recently celebrated its 30th anniversary providing treatment for cancer. This first virtual conference was hosted by CIO Bonn, a certified Comprehensive Cancer Center (CCC) funded by German Cancer Aid (DKH).
In addition to keynote speakers involved in CIK cell clinical trials or optimized preclinical models to improve this adoptive cell immunotherapy, more than 100 attendees from around the world also participated in this event. Initiatives to establish the International Society of CIK Cells (ISCC) and a stronger CIK cell network guiding preclinical research and future clinical trials were also announced.
论文信息
- 作者
- Sharma A、Ren X、Rosato A、Sangiolo D、Wang Z、Tettamanti S、Zhang Y、Rettinger E
- 第一作者单位
- Department of Integrated Oncology, Center for Integrated Oncology (CIO) Bonn, University Hospital Bonn, Bonn, Germany.Germany
- 通讯作者单位
- Department of Integrated Oncology, Center for Integrated Oncology (CIO) Bonn, University Hospital Bonn, Bonn, Germany. ingo.schmidt-wolf@ukbonn.de.Germany
- 期刊
- Cancer immunology, immunotherapy : CII2024 Jan 27
- 原文标识
- PubMed 38279995 · DOI 10.1007/s00262-023-03605-1
在 PubMed 查看 → 出版商原文（DOI） 全文 PDF（PMC）· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →